{"id":3829,"date":"2022-10-17T08:27:35","date_gmt":"2022-10-17T08:27:35","guid":{"rendered":"https:\/\/integratedcarejournal.com\/?p=3829"},"modified":"2022-10-17T08:27:35","modified_gmt":"2022-10-17T08:27:35","slug":"partners-protection-molnlycke-prevent-infections-elective-recovery","status":"publish","type":"post","link":"https:\/\/integratedcarejournal.com\/partners-protection-molnlycke-prevent-infections-elective-recovery\/","title":{"rendered":"\u2018Partners in Protection\u2019: How M\u00f6lnlycke works with clinicians to prevent infections and support elective recovery"},"content":{"rendered":"
Research from the Healthcare Safety Investigation Branch demonstrates that the COVID-19 pandemic has made people increasingly concerned about contracting infections in hospital settings.1<\/sup> Ensuring that patients have confidence that their treatment is safe, especially in the operating theatre, will be important to the uptake of planned and elective surgery to help tackle the backlog in care.2<\/sup><\/p>\n It is evident that breaking the chain of\u00a0preventable\u00a0infections\u00a0in hospitals should continue to be prioritised in the wake of the crisis. M\u00f6lnlycke aims to support healthcare professionals (HCPs) to face these challenges\u00a0by\u00a0offering solutions to significantly decrease the risk of surgical site infections (SSIs) in patients.<\/p>\n During the beginning of the pandemic, increased infection prevention and control protocols in operating theatres were introduced, which HCPs adapted to brilliantly. These additional measures required more preparation time, reducing the amount of time in the day available to complete operating procedures, and therefore resulting in fewer non-urgent patients being treated.3<\/sup><\/p>\n However, as the pandemic has progressed over the last two years, COVID-19 related infection prevention protocols have been adapted to help return the volume of elective care procedures to pre-pandemic capacity.3,4<\/sup> With the focus now on elective care recovery, we must ensure that infection prevention remains a top priority to support patient safety which does not fall off the agenda, and clinicians are adequately supported to deliver this in the operating theatre.<\/p>\n Most SSIs are caused by contamination of an incision with microorganisms from the patient’s own body during surgery.5<\/sup> While they can cause considerable harm to patients, up to 60 per cent of SSIs are preventable, demonstrating the need for the health system and its partners to actively work together to tackle the problem.6<\/sup><\/p>\n Ashford and St Peter\u2019s Hospitals NHS Foundation Trust is a notable example of how SSI rates can be reduced by assessing risk across the whole patient pathway. The Trust were able to put in place multiple changes simultaneously, from pre-operative chlorhexidine washing and patient pre-warming, through to an oozing wound protocol. Ashford and St Peter\u2019s were successful in reducing their early infection rate from 5 per cent to 0.24 per cent, which GIRFT<\/a> estimates saved the Trust \u00a32m. This proved adopting a multidisciplinary approach, in collaboration with industry partners, can have a positive impact on infection rates.7<\/sup><\/p>\n Additionally, creating an environment within clinical teams where there is open dialogue with patients, including providing education on SSIs, could be part of wider solutions. When patients are empowered with the information they need to prepare for surgery and to improve their chances of recovery, they can work collaboratively with clinical teams to make decisions about their own care. Ultimately, patient-centred approaches and patient safety should be at the heart of breaking the chain of infections.<\/p>\n
\nEffects of COVID-19 on infection control in elective care<\/h3>\n
\nHow can M\u00f6lnlycke\u2019s solutions help\u00a0\u2018break the chain of infection\u2019?<\/h3>\n